Article
Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasms.
European journal of cancer (Oxford, England : 1990) - 1 Jan 2014
Dubois Julie, Etienne Gabriel, Laroche-Clary Audrey, Lascaux Axelle, Bidet Audrey, Lippert Eric, Ait-ouferoukh Sofiane, Saada Veronique, Micol Jean-Baptiste, Bouabdallah Krimo, Robert Jacques
Abstract excerpt
PURPOSE: Myelodysplastic syndromes (MDS) are pre-leukaemic haematopoietic stem cell disorders. Among them, 10-20% occur after chemotherapy and/or radiotherapy, and are called 'therapy-related MDS' (t-MDS). The aim of this study was to identify genetic markers in t-MDS. METHODS: A prospective cohort of 59 MDS patients (39 de novo MDS, 20 t-MDS) was studied. A total of 384 single nucleotide polymorphisms (SNP)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
